glp 1 and stroke Frontiers Study design flow chart. Glp,
Description
An observational study of cardiovascular outcomes of tirzepatide vs glucagon-like peptide-1 receptor agonists
linkage to the Danish Diabetes Register showed that 698 of these 4714 individuals also had a T2D diagnosis
Cai Z, Wang S, Li J
(Lausanne) 14 , 1085799 (2023)
Results vary by individual, but typically, patients start to see noticeable weight loss within the first 8-12 weeks of starting the treatment
